rhTPO Dose Escalation vs Eltrombopag Switch in ITP
Clinical trial NCT07476846 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07476846
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2027-12-01
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.